InspireMD Inc

For the period ended Mar 31, 2024. Filed May 13, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 13, 2024

NSPR$0.71+2.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Changes in Equity

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(U.S. dollars in thousands, except share data)

Common stock · Series C Convertible Preferred Stock · Additional paid-in · Accumulated · Total
	Shares	Amount	Shares	Amount	capital	deficit	equity
BALANCE AT January 1, 2023	8,330,918	1	1,718	-*	218,977	(201,585)	17,393
Net loss			-	-		(4,256)	(4,256)
Share-based compensation related to restricted stock, restricted stock units and stock options award, net of forfeitures of 4,270 shares	(4,270)		-	-	289		289
BALANCE AT March 31, 2023	8,326,648	1	1,718	-*	219,266	(205,841)	13,426

*	Represents an amount less than $1 thousand

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(U.S. dollars in thousands, except share data)

Common stock · Series C Convertible Preferred Stock · Additional paid-in · Accumulated · Total
	Shares	Amount	Shares	Amount	capital	deficit	equity
BALANCE AT January 1, 2024	21,841,215	2	1,718	- *	261,000	(221,501)	39,501
Net loss			-	-		(7,032)	(7,032)
Share-based compensation related to stock, restricted stock, restricted stock units and stock options award, net of forfeitures of 75,090 shares	1,571,170		-	-	2,618		2,618
BALANCE AT March 31, 2024	23,412,385	2	1,718	-*	263,618	(228,533)	35,087

*	Represents an amount less than $1 thousand

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.